1.
In Situ Intestinal Absorption Kinetics of Sirolimus in Rats
西罗莫司大鼠在体肠吸收动力学研究
2.
Development of LC-MS application in measurement of sirolumus and everolimus;
液-质联用在西罗莫司和依维莫司血药浓度监测中的应用进展
3.
Preparation and Pharmacodynamics of Sirolimus New Drug Preparations;
西罗莫司新制剂的制备及体内药物动力学研究
4.
Mutagenesis of Streptomyces Hygroscopicus FC 904 and Biosynthesis on Sirolimus;
西罗莫司产生菌诱变育种和生物合成研究
5.
Application of Solid Dispersion Procedure in Sirolimus Capsule;
固体分散技术在西罗莫司胶囊中的应用
6.
Microbial Conversion of Sirolimus;
新型强效免疫抑制剂西罗莫司的微生物转化
7.
Study of Conversion Treatment with Sirolimus in Kidney Transplant Recipients;
西罗莫司在肾移植受者中的转换治疗研究
8.
Effects of Sirolimus on Renal Ischemia/Reperfusion Injury in Rats
西罗莫司对大鼠肾缺血再灌注损伤的影响
9.
THE EFFECT OF SIROLIMUS ON THE EXPRESSION OF HYPOXIA-INDUCIBLE FACTOR-1 ALPHA IN HEPATOCELLULAR CARCINOMA HEPG2 CELLS
西罗莫司对肝癌HepG2细胞中HIF-1α表达影响
10.
Angiographic pattern of restenosis following implantation of overlapping sirolimus-elu-ting (Cypher) stents
重叠西罗莫司洗脱支架置入后的血管造影再狭窄类型
11.
Objective To observe the effect of application of Sirolimus on adventitia in preventing stenosis of vein graft.
目的探讨血管外膜应用西罗莫司对静脉移植物再狭窄的作用。
12.
Clinical Research of Conversion Treatment with Sirolimus-based Immunosuppressive Protocol after Liver Transplantation;
以西罗莫司为基础的免疫抑制方案在肝移植后应用的临床研究
13.
The Growth Inhibitory Effects of Sirolimus on RCC 786-O Cell Line in Vitro;
西罗莫司对肾癌786-O细胞株体外培养的生长抑制作用
14.
Concentration Monitoring in Whole Blood, Clinical Application and Safety Evaluation of Sirolimus in Allo-HSCT Patients;
西罗莫司在allo-HSCT患者的全血药浓度监测、临床应用和安全性评价
15.
Effect of Sirolimus on the Expression of HIF-1α and VEGF in Hepatocellular Carcinoma HepG2 Cells in Vitro
西罗莫司对体外培养肝癌细胞株HIF-1α、VEGF表达的影响
16.
The Experiment Study on the Inhibition of Proliferation and Induction of Apoptosis by Sirolimus in Rat C6 Glioma Cells
西罗莫司对C6鼠胶质瘤细胞增殖抑制和诱导凋亡实验研究
17.
Clinical outcomes of unrestricted application of domestic Sirolimus-eluting stent
真实临床条件下国产西罗莫司药物支架的临床评价
18.
Sirolimus inhibits cell proliferation and downregulates mTOR and HIF-1α expression in human hepatic carcinoma HepG2 cells
西罗莫司对肝癌HepG2细胞的增殖及mTOR、HIF-1α的抑制作用